A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma
ObjectiveWe sought to develop and validate a novel prognostic model for predicting survival of patients with Barcelona Clinic Liver Cancer Stages (BCLC) stage B hepatocellular carcinoma (HCC) using a machine learning approach based on random survival forests (RSF).MethodsWe retrospectively analyzed...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.608260/full |
id |
doaj-4dddd93f2d8b406a93e6ec1b38923246 |
---|---|
record_format |
Article |
spelling |
doaj-4dddd93f2d8b406a93e6ec1b389232462021-03-02T15:06:07ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-03-011110.3389/fonc.2021.608260608260A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular CarcinomaHuapeng Lin0Huapeng Lin1Lingfeng Zeng2Jing Yang3Wei Hu4Ying Zhu5Department of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Nephrology, The Second Xiangya Hospital of Central South University, Changsha, ChinaDepartment of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Intensive Care Unit, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaObjectiveWe sought to develop and validate a novel prognostic model for predicting survival of patients with Barcelona Clinic Liver Cancer Stages (BCLC) stage B hepatocellular carcinoma (HCC) using a machine learning approach based on random survival forests (RSF).MethodsWe retrospectively analyzed overall survival rates of patients with BCLC stage B HCC using a training (n = 602), internal validation (n = 301), and external validation (n = 343) groups. We extracted twenty-one clinical and biochemical parameters with established strategies for preprocessing, then adopted the RSF classifier for variable selection and model development. We evaluated model performance using the concordance index (c-index) and area under the receiver operator characteristic curves (AUROC).ResultsRSF revealed that five parameters, namely size of the tumor, BCLC-B sub-classification, AFP level, ALB level, and number of lesions, were strong predictors of survival. These were thereafter used for model development. The established model had a c-index of 0.69, whereas AUROC for predicting survival outcomes of the first three years reached 0.72, 0.71, and 0.73, respectively. Additionally, the model had better performance relative to other eight Cox proportional-hazards models, and excellent performance in the subgroup of BCLC-B sub-classification B I and B II stages.ConclusionThe RSF-based model, established herein, can effectively predict survival of patients with BCLC stage B HCC, with better performance than previous Cox proportional hazards models.https://www.frontiersin.org/articles/10.3389/fonc.2021.608260/fullhepatocellular carcinomaBCLC Stage Bmachine learningrandom survival forestprognosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Huapeng Lin Huapeng Lin Lingfeng Zeng Jing Yang Wei Hu Ying Zhu |
spellingShingle |
Huapeng Lin Huapeng Lin Lingfeng Zeng Jing Yang Wei Hu Ying Zhu A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma Frontiers in Oncology hepatocellular carcinoma BCLC Stage B machine learning random survival forest prognosis |
author_facet |
Huapeng Lin Huapeng Lin Lingfeng Zeng Jing Yang Wei Hu Ying Zhu |
author_sort |
Huapeng Lin |
title |
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma |
title_short |
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma |
title_full |
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma |
title_fullStr |
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma |
title_full_unstemmed |
A Machine Learning-Based Model to Predict Survival After Transarterial Chemoembolization for BCLC Stage B Hepatocellular Carcinoma |
title_sort |
machine learning-based model to predict survival after transarterial chemoembolization for bclc stage b hepatocellular carcinoma |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-03-01 |
description |
ObjectiveWe sought to develop and validate a novel prognostic model for predicting survival of patients with Barcelona Clinic Liver Cancer Stages (BCLC) stage B hepatocellular carcinoma (HCC) using a machine learning approach based on random survival forests (RSF).MethodsWe retrospectively analyzed overall survival rates of patients with BCLC stage B HCC using a training (n = 602), internal validation (n = 301), and external validation (n = 343) groups. We extracted twenty-one clinical and biochemical parameters with established strategies for preprocessing, then adopted the RSF classifier for variable selection and model development. We evaluated model performance using the concordance index (c-index) and area under the receiver operator characteristic curves (AUROC).ResultsRSF revealed that five parameters, namely size of the tumor, BCLC-B sub-classification, AFP level, ALB level, and number of lesions, were strong predictors of survival. These were thereafter used for model development. The established model had a c-index of 0.69, whereas AUROC for predicting survival outcomes of the first three years reached 0.72, 0.71, and 0.73, respectively. Additionally, the model had better performance relative to other eight Cox proportional-hazards models, and excellent performance in the subgroup of BCLC-B sub-classification B I and B II stages.ConclusionThe RSF-based model, established herein, can effectively predict survival of patients with BCLC stage B HCC, with better performance than previous Cox proportional hazards models. |
topic |
hepatocellular carcinoma BCLC Stage B machine learning random survival forest prognosis |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.608260/full |
work_keys_str_mv |
AT huapenglin amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT huapenglin amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT lingfengzeng amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT jingyang amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT weihu amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT yingzhu amachinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT huapenglin machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT huapenglin machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT lingfengzeng machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT jingyang machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT weihu machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma AT yingzhu machinelearningbasedmodeltopredictsurvivalaftertransarterialchemoembolizationforbclcstagebhepatocellularcarcinoma |
_version_ |
1724234743755571200 |